Catalyst Clinical Research
Catalyst Clinical Research, LLC is a contract research organization based in Durham, North Carolina, specializing in providing staffing services and clinical operation solutions to biotechnology, pharmaceutical, and medical device companies. Established in 2013, the company leverages over two decades of industry experience to support clinical development programs with therapeutically-aligned professionals and customized solutions. Catalyst focuses on oncology and offers a range of clinical trial services, including multi-therapeutic resourcing and functional solutions. By simplifying clinical research data, the organization aims to accelerate critical trial decisions, particularly in early-phase studies, thereby facilitating the development of next-generation cancer therapies for patients.
Top Stages
4 past transactions
Genpro Research
Acquisition in 2023
Genpro Research is a consulting firm specializing in the pharmaceutical, biotechnology, and medical device sectors. It offers expert services in biostatistics and programming, medical writing, and regulatory submissions. The company assists clients in navigating complex statistical issues during study design and analysis, with a particular focus on adaptive designs. Additionally, Genpro Research provides guidance on incorporating and analyzing the effectiveness of statistical methodologies in clinical trials, helping clients at various stages of their business.
Aptus Clinical
Acquisition in 2022
Aptus Clinical is a specialized contract research organization (CRO) that provides comprehensive clinical research services, particularly in the fields of oncology, cell and gene therapies, and rare diseases. The company focuses on the design, conduct, and delivery of early-phase clinical studies, offering a range of services including project management, site monitoring, data management, statistical analysis, programming, and medical monitoring. By delivering tailored solutions, Aptus Clinical assists life science companies in transforming innovative scientific research into effective medicines, while optimizing their clinical development processes and enhancing their research capabilities.
Ce3
Acquisition in 2020
Ce3 Inc. is a specialized oncology contract research organization based in Clinton, Connecticut, that provides early-phase clinical development services to the biotechnology industry. Established in 2005, the company focuses on oncology and emphasizes novel treatment modalities, including immuno-oncology and cell and gene therapies. Ce3 is dedicated to understanding the unique needs of biotechnology companies and aims to deliver high-quality, cost-effective solutions that support clients in achieving their analytical, regulatory, and investor objectives. As of August 2020, Ce3 operates as a subsidiary of Catalyst Clinical Research, LLC.
Triangle Biostatistics
Acquisition in 2019
Triangle Biostatistics is a pharmaceutical company that specializes in biostatistics and statistical programming services. It offers a range of services, including statistical consulting and data management, tailored to meet the needs of the pharmaceutical, biotechnology, and medical device industries. The company is committed to delivering innovative and high-quality biometric solutions, utilizing sound scientific reasoning and advanced computing technology to support its clients in their research and development efforts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.